Loading
SC
Stem Cell Therapy International, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Stark David, was filed 11 Feb 2009.
Stem Cell Therapy International, Inc.: what insiders have been doing
Stem Cell Therapy International, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Stem Cell Therapy International, Inc. in twelve months, the latest record being from 26 October 2009.
Over the whole record (from 2008), the tally stands at 2 purchases and 2 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
6
Thresholds
n/a
Buy Volume
€722
2 ops. · all time
Sell Volume
€2,223
2 ops. · all time
Last declaration on 26 October 2009
Declarations6 total
5,000 shares@ US$0.325Common StockSEC:0001474725-09-000001:0
5,000 shares@ US$0.33Common StockSEC:0001474725-09-000001:1
1,000,000 shares@ US$0.059Common StockSEC:0001181431-09-043209:0
1,462 shares@ US$0.06Common StockSEC:0001181431-09-007823:0
Canonical exit: 11 Mar 2009 (T+90)
12,500 shares@ US$0.07Common StockSEC:0001181431-09-007823:1
Canonical exit: 11 Mar 2009 (T+90)
900,000 shares0Common StockSEC:0001360865-08-000039:0
6 of 6 declarations
About Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. is a company focused on developing stem cell-based therapies. It is listed on NASDAQ under the ticker XNAS.
